December 10 2021: The Daily Research News Online site, MrWeb, reports, that…”Pharma specialist M3 Global Research has announced the acquisition of Sydney, Australia-based fieldwork firm Ekas Marketing.
The acquiring firm is part of the M3 Group, publicly traded company as M3 Inc. on the Tokyo Stock Exchange, which operates in the US, Asia and Europe and counts more than six million physician members globally via web sites including mdlinx.com, m3.com, doctors.net.uk and m3india.
In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Japan, UK, France, Germany, Spain, USA, Sweden, China, South Korea, and India.
Ekas, which celebrates its 50th birthday this year and whose tagline is ‘We are Australians, We know Australians’, provides data collection and analysis services for a range of sectors, including b2b and consumer markets but with healthcare strongly represented. It also partners with other firms and individuals to offer a full service package. M3 says the acquired firm’s ISO certified panel further strengthens its own proprietary healthcare panel, described as the world’s largest; and that the buy – its eighth MR business and its first in the ANZ region – further consolidates its APAC base following the successful onboarding of healthcare panels firm m-panels in 2020.”
For the full article go to MrWeb